Non-steroidal anti-inflammatory drugs selectively inhibit cytokine production by NK cells and γδ T cells

Experimental Dermatology

Volumn 15, Issue 12, 2006, Pages 981-990

  Inaoka, Miyuki ^a   Kimishima, Momoko ^a   Takahashi, Ryo ^a   Shiohara, Tetsuo ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

T cells; Cytokine; Human; Innate immunity; Natural killer cells

Indexed keywords

ACETYLSALICYLIC ACID; BUFEXAMAC; CYTOKINE; GAMMA INTERFERON; INDOMETACIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROSTAGLANDIN SYNTHASE; PYRUVATE SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLERGIC DISEASE; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DRUG HYPERSENSITIVITY; DRUG SELECTIVITY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MALE; NATURAL KILLER CELL; PHENOTYPE; T LYMPHOCYTE; TH2 CELL; VIRUS INFECTION;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUFEXAMAC; CELLS, CULTURED; CYCLOOXYGENASE INHIBITORS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY; INTERFERON TYPE II; KILLER CELLS, NATURAL; MALE; MONOCYTES; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33750630391     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2006.00505.x     Document Type: Article

References (38)

1. Starko K M, Ray C G, Dominguez L B, Stromberg W L, Woodall D F. Reye's syndrome and salicylate use. Pediatrics 1980: 66: 859-864.
2. Belay E D, Bresee J S, Holman R C. Reye's syndrome in the United States from 1981 through 1997. N Engl J Med 1999: 340: 1377-1382.
3. American Academy of Pediatrics. Committee on Infectious Diseases. Severe invasive group A streptococcal infections: A subject review. Pediatrics 1998: 101: 136-140.
4. Lesko S M, O'Brien K L, Schwartz B, Vezina R, Mitchell A A. Invasive group A streptococcal infection and nonsteroidal anti-inflammatory drug use among children with primary varicella. Pediatrics 2001: 107: 1108-1115.
5. Clark I, Whitten R, Molyneux M, Taylor T. Salicylates, nitric oxide, malaria, and Reye's syndrome. Lancet 2001: 357: 625-627.
6. Campanile F, Giampietri A, Grohmann U, Binaglia L, Fioretti M C, Puccetti P. Accelerated hematopoietic recovery and protective effect of the cyclooxygenase inhibitor indomethacin in bacterial infection of neutropenic mice. Cell Immunol 1993: 147: 341-352.
7. Stevens M G, Pugh G W Jr, Tabatabai L B. Effects of gamma interferon and indomethacin in preventing Burcella abortus infections in mice. Infect Immun 1992: 60: 4407-4409.
8. Tay C H, Szomolanyi-Tsuda E, Welsh R M. Control of infections by NK cells. Curr Top Microbiol Immunol 1998: 230: 193-220.
9. Delves P J, Roitt I M. The immune system. N Engl J Med 2000: 343: 37-49.
10. Shiohara T, Mizukawa Y, Teraki Y, Fukuda T. Gamma-Delta T cells with emphasis on their functional role in the epidermis. Chem Immunol 2001: 79: 66-86.
11. Biron C A, Nguyen K B, Pien G C, Cousins L P, Salazar T P. Natural killer cells in antiviral defense: Function and regulation by innate cytokines. Annu Rev Immunol 1999: 17: 189-220.
12. Hayday A C. γδ cells: A right time and a right place for a conserved third way of protection. Annu Rev Immunol 2000: 18: 975-1026.
13. Gómez-Gaviro M V, Dominguez-Jiménez C, Carretero J M et.al. Down-regulation of L-selectin expression in neutrophils by nonsteroidal anti-inflammatory drugs: Role of intracellular ATP concentration. Blood 2000: 96: 3592-3600.
14. Christiansen J V, Gadborg E, Kleiter I et al. Efficacy of bufexamac (NFN) cream in skin diseases. Dermatologica1 1997: 54: 177-184.
15. Harada S, Horikawa T, Ashida M, Kamo T, Nishioka E, Ichihashi M. Aspirin enhances the induction of type I allergic symptoms when combined with food and exercise in patients with food-dependent exercise-induced anaphylaxis. Br J Dermatol 2001: 145: 336-339.
16. Eneli I, Sadri K, Camargo C Jr, Barr R G. Acetaminophen and the risk of asthma: The epidemiologic and pathophysiologic evidence. Chest 2005: 127: 604-612.
17. Body R, Potier K. Non-steroidal anti-inflammatory drugs and exacerbations of asthma in children. Emerg Med J 2004: 21: 713-714.
18. Katsuta M, Takigawa Y, Kimishima M, Inaoka M, Takahashi R, Shiohara T. NK cells and γδ + T cells are phenotypically and functionally defective due to preferential apoptosis in patients with atopic dermatitis. J Immunol 2006: 176: 7736-7744.
19. Mizukawa Y, Yamazaki Y, Teraki Y, Hayakawa J, Hayakawa K, Nuriya H. Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption. Am J Pathol 2002: 161: 1337-1347.
20. Lahn M, Kalataradi H, Mittelstadt P et.al. Early preferential stimulation of γδ T cells by TNF- α. J Immunol 1998: 160: 5221-5230.
21. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med 1998: 104: 413-421.
22. Riendeau D, Percival M D, Brideau C et al. Etoricoxib (MK-0663): preclinical profile and comparison with other agents that selectively inhibit cyclooxygenase-2. J Pharmacol Exp Ther 2001: 296: 558-566.
23. Ma A, Boone D L, Lodolce J P. The pleiotropic functions of interleukin 15: Not so interleukin 2-like after all. J Exp Med 2000: 191: 753-756.
24. bright subset. Blood 2001: 97: 3146-3151.
25. Ranson T, Vosshenrich C A, Corcuff E, Richard O, Muller W, Di Santo J P. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 2003: 101: 4887-4893.
26. -NK cells: A regulatory role of monocytes and IL-10. J Immunol 2000: 165: 139-147.
27. Kopp E, Ghosh S. Inhibition of NF-κ B by sodium salicylate and aspirin. Science 1994: 265: 956-999.
28. Cianferoni A, Schroeder J T, Kim J et al. Selective inhibition of interleukin-4 gene expression in human T cells by aspirin. Blood 2001: 97: 1742-1749.
29. Baumer W, Krekeler S, DeVries V C, Niedorf F, Tschering T, Kietzmann M. Non-steroidal and steroidal anti-inflammatory drugs vary in their modulation of dendritic cell function in the elicitation phase of allergic contact dermatitis. Exp Dermatol 2006: 15: 322-329.
30. Asero R. Intolerance to nonsteroidal anti-inflammatory drugs might precede by years the onset of chronic urticaria. J Allergy Clin Immunol 2003: 111: 1095-1098.
31. Koch P, Bahmer F A. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: Report of 4 cases. Contact Dermatitis 1994: 31: 97-101.
32. Kurumaji Y. Photo Koebner phenomenon in erythema-multiforme-like eruption induced by contact dermatitis due to bufexamac. Dermatology 1998: 197: 183-186.
33. Shiohara T, Moriya N, Hayakawa J, Itohara S, Ishikawa H. Resistance to cutaneous graft-vs.-host disease is not induced in T cell receptor delta gene-mutant mice. J Exp Med 1996: 183: 1483-1489.
34. Mak T W, Ferrick D A. The γδ T-cell bridge: Linking innate and acquired immunity. Nat Med 1998: 4: 764-765.
35. Peritt D, Robertson S, Gri G, Showe L, Aste-Amezaga M, Trinchieri G. Differentiation of human NK cells into NK1 and NK2 subsets. J Immunol 1998: 161: 5821-5824.
36. Medzhitov R, Janeway C A Jr. Innate immunity: Impact on the adaptive immune response. Curr Opin Immunol 1997: 9: 4-9.
37. Fu Y-X, Roark C E, Kelly K, Drevets D, Campbell P, O'Brien R et.al. Immune protection and control of inflammatory tissue necrosis by γδ T cells. J Immunol 1994: 153: 3101-3115.
38. Varner A E, Busse W W, Lemanske R F. Hypothesis: Decreased use of pediatric aspirin has contributed to the increasing prevalence of childhood asthma. Ann Allergy Asthma Immunol 1998: 81: 347-351.